Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-324693
Filing Date
2018-11-13
Accepted
2018-11-13 06:32:47
Documents
4
Period of Report
2018-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d651775d6k.htm 6-K 157964
2 GRAPHIC g651775g06e75.jpg GRAPHIC 1563
3 GRAPHIC g651775g13w53.jpg GRAPHIC 8090
4 GRAPHIC g651775g80b83.jpg GRAPHIC 4949
  Complete submission text file 0001193125-18-324693.txt   179582
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 181174892
SIC: 2834 Pharmaceutical Preparations